AhR and PPARα:: antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11

被引:33
|
作者
Shaban, Z
Soliman, M
El-Shazly, S
El-Bohi, K
Abdelazeez, A
Kehelo, K
Kim, HS
Muzandu, K
Ishizuka, M
Kazusaka, A
Fujita, S
机构
[1] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci,Toxicol Lab, Kita Ku, Sapporo, Hokkaido 0600818, Japan
[2] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Biochem Lab, Sapporo, Hokkaido 0600818, Japan
[3] Tanta Univ, Fac Vet Med, Dept Biochem & Physiol, Tanta, Egypt
关键词
AhR; PPAR alpha; CYP2B; CYP2C11; CYP3A;
D O I
10.1080/00498250400021804
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates a spectrum of toxic and biological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin ( TCDD) and related compounds. The peroxisome proliferator-activated receptor alpha (PPAR alpha) is a member of the nuclear receptor super-family of ligand-activated transcription factors and it functions as an obligate heterodimer with retinoid X-receptor alpha RXR alpha. The aim was to investigate whether the negative cross-talk recently proposed by the present authors between AhR and PPAR alpha on CYP4A and CYP1A has any impact on other cytochrome P450 enzymes. Treatment of male Wistar rats with a PPAR alpha ligand clofibric acid (CA) induced CYP2B1/2 and CYP3A proteins, activities, and the mRNA expression of CYP2B1, CYP2B2, CYP3A1 and CYP3A2, and suppressed CYP2C11 protein, activities and mRNA expression. AhR ligand Sudan III (S.III) treatment decreased basal and CA-induced CYP2B, CYP3A and CYP2C11 protein, activities and mRNA expression. To the best of the authors' knowledge, this is the first study showing the presence of mutual effects of AhR and PPAR alpha on CYP2B and CYP3A and an additive inhibitory effect on CYP2C11 in the livers of male rats.
引用
收藏
页码:51 / 68
页数:18
相关论文
共 50 条
  • [1] Comparative effects of resveratrol and trans-stilbene oxide on rat hepatic microsomal CYP2B, CYP2C11, CYP3A, and epoxide hydrolase expression.
    Chang, TKH
    Ho, JY
    Fung, DWY
    Bandiera, SM
    FASEB JOURNAL, 1999, 13 (05): : A814 - A814
  • [2] Pituitary component of the aromatic hydrocarbon-mediated expression of CYP2B and CYP2C11
    Bergeron, RM
    Serron, SC
    Rinehart, JJ
    Cawley, GF
    Backes, WL
    XENOBIOTICA, 1998, 28 (03) : 303 - 312
  • [3] CYP2C and CYP2B Mediated Metabolic Activation of Retrorsine in Cyp3a Knockout Mice
    Pang, Xiaoyan
    Tang, Chongzhuang
    Kong, Fandi
    Chen, Meixia
    Chen, Xiaoyan
    CURRENT DRUG METABOLISM, 2020, 21 (13) : 1040 - 1051
  • [4] INDUCTION OF VARIOUS CYTOCHROMES CYP2B, CYP2C AND CYP3A BY PHENOBARBITONE IN NONHUMAN-PRIMATES
    JONES, CR
    GUENGERICH, FP
    RICE, JM
    LUBET, RA
    PHARMACOGENETICS, 1992, 2 (04): : 160 - 172
  • [5] Lycopene increases metabolic activity of rat liver CYP2B, CYP2D and CYP3A
    Noskova, Kristyna
    Dovrtelova, Gabriela
    Zendulka, Ondrej
    Strakosova, Marketa
    Pes, Ondrej
    Jurica, Jan
    PHARMACOLOGICAL REPORTS, 2020, 72 (01) : 156 - 165
  • [6] Lycopene increases metabolic activity of rat liver CYP2B, CYP2D and CYP3A
    Kristýna Nosková
    Gabriela Dovrtělová
    Ondřej Zendulka
    Markéta Strakošová
    Ondřej Peš
    Jan Juřica
    Pharmacological Reports, 2020, 72 : 156 - 165
  • [7] INHIBITION OF CYP1A, CYP2B, AND CYP3A ACTIVITIES BY 5HT3 ANTAGONISTS
    GAN, LS
    BOEHLERT, C
    THAKKER, D
    SERABJITSINGH, C
    FASEB JOURNAL, 1994, 8 (07): : A1248 - A1248
  • [8] INHIBITORY EFFECTS OF SEVERAL CYP3A INHIBITORS ON CYP3A ACTIVITY IN CATS
    Shah, Syed S.
    Hayashi, Yuhei
    Motoyama, Seiko
    Sasaki, Kazuaki
    Shimoda, Minoru
    DRUG METABOLISM REVIEWS, 2008, 40 : 58 - 58
  • [9] Effect of arsenite on induction of CYP1A, CYP2B, and CYP3A in primary cultures of rat hepatocytes
    Jacobs, JM
    Nichols, CE
    Andrew, AS
    Marek, DE
    Wood, SG
    Sinclair, PR
    Wrighton, SA
    Kostrubsky, VE
    Sinclair, JF
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 157 (01) : 51 - 59
  • [10] EXPRESSION OF THE CYP3A AND CYP2C11 ENZYMES IN A NUTRITIONALLY OBESE RODENT MODEL - RESPONSE TO PHENOBARBITAL TREATMENT
    ZANNIKOS, PN
    BANDYOPADHYAY, AM
    ROBERTSON, LW
    BLOUIN, RA
    INTERNATIONAL JOURNAL OF OBESITY, 1994, 18 (06) : 369 - 374